The Tri-Institutional MD-PhD Program (Tri-I) is a joint undertaking between Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center. Trainees complete their MD degree at Weill Cornell Medical College, and PhD training at one of the three participating graduate schools: Weill Cornell Graduate School of Medical Sciences; the David Rockefeller Graduate Program in Bioscience; or the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences. Tri-I guides students through a rigorous course of study that offers flexibility and unfettered access to experienced mentors in leading laboratories. An integrated curriculum reinforces the students’ identities as clinician-scientists; equally well-prepared to work in the laboratory and at the bedside, Tri-I graduates bridge the gap between clinical medicine and laboratory research. 

Learn more about the Tri-Institutional MD-PhD Program by watching the short video below.

A
In 2013, scientists at MIT and at UC Berkeley optimized a way to use bacterial gene sequences to cut and change DNA at precise locations. The genome-editing system, called CRISPR, is cheaper and simpler than previous methods, and it has led to breakthroughs in diagnostics and the creation of more accurate disease models.
Fifth year Tri-Instutional MD-PhD student, Jay Shi, has been awarded an F30 fellowship from the National Institutes of Health's National Cancer Institute for his project "Dynamic Organization of Cell Architecture in Multicellular Tissues."